The SIDER database of drugs and side effects
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Unwanted side effects of drugs are a burden on patients and a severe impediment in the development of new drugs. At the same time, adverse drug reactions (ADRs) recorded during clinical trials are an important source of human phenotypic data. It is therefore essential to combine data on drugs, targets and side effects into a more complete picture of the therapeutic mechanism of actions of drugs and the ways in which they cause adverse reactions. To this end, we have created the SIDER ('Side Effect Resource', http://sideeffects.embl.de) database of drugs and ADRs. The current release, SIDER 4, contains data on 1430 drugs, 5880 ADRs and 140 064 drug-ADR pairs, which is an increase of 40% compared to the previous version. For more fine-grained analyses, we extracted the frequency with which side effects occur from the package inserts. This information is available for 39% of drug-ADR pairs, 19% of which can be compared to the frequency under placebo treatment. SIDER furthermore contains a data set of drug indications, extracted from the package inserts using Natural Language Processing. These drug indications are used to reduce the rate of false positives by identifying medical terms that do not correspond to ADRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“One of the most widely utilized ADE databases derived from drug label data is SIDER, constructed using a dictionary-based named entity recognition (NER) method to extract adverse event terms from FDA Structured Product Labeling (SPLs) drug labels13.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
Self-citationDrug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · cited 1×
“For example, it was shown that ADRs can be used to predict drug targets (1) and that causal relations between targets and ADRs can be elucidated (2,3).”
BackgroundSelf-citationThe Stanford typed dependencies representation
de Marneffe, M.-C., & Manning, C. D. (2008) · Coling 2008: Proceedings of the workshop on Cross-Framework and Cross-Domain Parser Evaluation - CrossParser '08 · doi:10.3115/1608858.1608859 · Cited by 918
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Self-citationPREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
STITCH 4: integration of protein–chemical interactions with user data
Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J., & Bork, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1207 · Cited by 487
Self-citationExtraction of potential adverse drug events from medical case reports
Gurulingappa, H., Mateen‐Rajpu, A., & Toldo, L. (2012) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-3-15 · Cited by 211
The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text
Pafilis, E., Frankild, S. P., Fanini, L., Faulwetter, S., Pavloudi, C., Vasileiadou, A., Arvanitidis, C., & Jensen, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065390 · Cited by 206
Self-citationCai, M., Xu, Q., Pan, Y.-J., Pan, W., Ji, N., Li, Y.-B., Jin, H.-J., Liu, K., & Ji, Z. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1066 · Cited by 131
Systematic identification of proteins that elicit drug side effects
Kuhn, M., Al Banchaabouchi, M., Campillos, M., Jensen, L. J., Gross, C., Gavin, A., & Bork, P. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.10 · Cited by 120
Self-citation
Cited by
Items 701–800 of 1,001
PatientEG Dataset: Bringing Event Graph Model with Temporal Relations to Electronic Medical RecordsPreprint
Liu, X., Jin, J., Wang, Q., Ruan, T., Zhou, Y., Gao, D., & Yin, Y. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1812.09905 · Cited by 12
Lost in Translation: Chemical Language Models and the Misunderstanding of Molecule Structures
Ganeeva, V., Sakhovskiy, A., Khrabrov, K., Savchenko, A., Kadurin, A., & Tutubalina, E. V. (2024) · Findings of the Association for Computational Linguistics: EMNLP (Findings of EMNLP) · doi:10.18653/v1/2024.findings-emnlp.760 · Cited by 12
ADHD-KG: a knowledge graph of attention deficit hyperactivity disorder
Papadakis, E., Baryannis, G., Batsakis, S., Adamou, M., Huang, Z., & Antoniou, G. (2023) · Health Information Science and Systems · doi:10.1007/s13755-023-00253-8 · Cited by 11
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency
Iwata, H. (2024) · Bioanalysis · doi:10.1080/17576180.2024.2437283 · Cited by 11
Dotolo, S., Marabotti, A., Rachiglio, A. M., Abate, R. E., Benedetto, M., Ciardiello, F., Luca, A. D., Normanno, N., Facchiano, A. M., & Tagliaferri, R. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab180 · Cited by 11
Alibilli, A. S., Jain, V., Mane, H., Yue, X., Ratzki‐Leewing, A. A., Merchant, J. S., Criss, S., Nguyen, Q. C., McCoy, R. G., & Nguyen, T. T. X. (2025) · JMIR Infodemiology · doi:10.2196/73619 · Cited by 11
Quantitative and qualitative concordance between clinical and nonclinical toxicity data
Weitekamp, C. A., Friedman, K. P., Harrill, A. H., Auerbach, S., Bandele, O. J., Barton‐Maclaren, T. S., Fitzpatrick, S., Mezencev, R., Santillo, M. F., Simanainen, U., et al. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf071 · Cited by 11
Application of Network Pharmacology Based on Artificial Intelligence Algorithms in Drug Development
Zhou, W., Li, X., Han, L., & Fan, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-0753-0_2 · Cited by 11
PathWalks: identifying pathway communities using a disease-related map of integrated information
Karatzas, E., Zachariou, M., Bourdakou, M. M., Minadakis, G., Oulas, A., Kolios, G. C., Delis, A., & Spyrou, G. M. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa291 · Cited by 11
Transporter proteins knowledge graph construction and its application in drug development
Chen, X.-H., Ruan, Y., Liu, Y., Duan, X., Jiang, F. X., Tang, H., Zhang, H., & Zhang, Q. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.05.001 · Cited by 11
Metabolic Network Reconstructions to Predict Drug Targets and Off-Target Effects
Rawls, K. D., Dougherty, B. V., & Papin, J. A. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0159-4_14 · Cited by 11
Drug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial Regimens
Falvo, P., Orecchioni, S., Roma, S., Raveane, A., & Bertolini, F. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200817104912 · Cited by 11
Lee, S.-G., Rhee, J., Seok, J., Kim, J. H., Kim, M. W., Song, G.-E., Park, S., Jeong, K. S., Lee, S., Lee, Y. H., et al. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae029 · Cited by 11
Evaluating molecular fingerprint-based models of drug side effects against a statistical control
Alpay, B. A., Gosink, M. M., & Aguiar, D. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103364 · Cited by 11
Dynamic Embeddings for Interaction Prediction
Kefato, Z. T., Girdzijauskas, Š., Sheikh, N., & Montresor, A. (2021) · International World Wide Web Conference (WWW) · doi:10.1145/3442381.3450020 · Cited by 11
Chemogenomic Approaches for Revealing Drug Target Interactions in Drug Discovery
Bhargava, H., Sharma, A., & Suravajhala, P. (2021) · Current Genomics · doi:10.2174/1389202922666210920125800 · Cited by 11
Network medicine and systems pharmacology approaches to predicting adverse drug effects
Funari, A., Fiscon, G., & Paci, P. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17330 · Cited by 11
Torres, L. H. M., Arrais, J. P., & Ribeiro, B. (2023) · Neural Computing and Applications · doi:10.1007/s00521-023-08403-5 · Cited by 11
Heyrati, M. P., Ghorbanali, Z., Akbari, M., Pishgahi, G., & Zare‐Mirakabad, F. (2023) · ACS Omega · doi:10.1021/acsomega.3c05778 · Cited by 11
Fine-grained selective similarity integration for drug–target interaction prediction
Liu, B., Wang, J., Sun, K., & Tsoumakas, G. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad085 · Cited by 11
KnoMol: A Knowledge-Enhanced Graph Transformer for Molecular Property Prediction
Gao, J. F., Shen, Z., Lu, Y., Shen, L., Zhou, B., Xu, D., Dai, H., Xu, L., Che, J., & Dong, X. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01092 · Cited by 11
Kianfar, A., Razzaghi, P., & Asgari, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-92218-y · Cited by 11
Roy, A., & Chaguturu, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801814-9.00003-9 · Cited by 11
A Literature Review of Social Media-Based Data Mining for Health Outcomes Research
Ru, B., & Yao, L. (2019) · Springer eBooks · doi:10.1007/978-3-030-14714-3_1 · Cited by 11
WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking
Liu, Y., Dong, H., Wang, X., Moretti, R., Wang, Y., Su, Z., Gu, J., Bodenheimer, B., Weaver, C., Meiler, J., et al. (2024) · neural information processing systems · doi:10.52202/079017-1686 · Cited by 11
Graph Neural Networks in Natural Language Processing
Ma, Y., & Tang, J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108924184.015 · Cited by 10
Wang, Y., Lv, J., Xia, Y., Xu, J., Meng, Y., Cui, F., Wei, L., Zou, Q., & Zhang, Z. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.108843 · Cited by 10
Graph Neural Networks in Data Mining
Ma, Y., & Tang, J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108924184.017 · Cited by 10
Making the most effective use of available computational methods for drug repositioning
Gori, D. N. P., Alberca, L. N., & Talevi, A. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2198700 · Cited by 10
Jiang, Y., Rensi, S., Wang, S., & Altman, R. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.17.385757 · Cited by 10
Construction of heterogeneous medical knowledge graph from electronic health records
Mythili, R., Parthiban, N., & Kavitha, V. (2022) · Journal of Discrete Mathematical Sciences and Cryptography · doi:10.1080/09720529.2022.2068604 · Cited by 10
A Multi‐Dimensional Approach to Map Disease Relationships Challenges Classical Disease Views
Möbus, L., Serra, A., Fratello, M., Pavel, A., Federico, A., & Greco, D. (2024) · Advanced Science · doi:10.1002/advs.202401754 · Cited by 10
Zhang, M., Hong, Y., Shen, L., Xu, S., Xu, Y., Zhang, X., Liu, J., & Liu, X. (2024) · Future Generation Computer Systems · doi:10.1016/j.future.2024.05.054 · Cited by 10
A Modified Skip-Gram Algorithm for Extracting Drug-Drug Interactions from AERS Reports
Wang, L., Pan, W., Wang, Q., Bai, H., Liu, W., Jiang, L., & Zhang, Y. (2020) · Computational and Mathematical Methods in Medicine · doi:10.1155/2020/1747413 · Cited by 10
Tissue‐Specific Analysis of Pharmacological Pathways
Hao, Y., Quinnies, K. M., Realubit, R. B., Karan, C., & Tatonetti, N. P. (2018) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12305 · Cited by 10
A new integrated framework for the identification of potential virus–drug associations
Qu, J., Song, Z., Cheng, X., Jiang, Z., & Zhou, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1179414 · Cited by 10
Advances in Predicting Drug Functions: A Decade-Long Survey in Drug Discovery Research
Das, P., & Mazumder, D. H. (2023) · IEEE Transactions on Molecular Biological and Multi-Scale Communications · doi:10.1109/tmbmc.2023.3345145 · Cited by 10
Béquignon, O. J. M., Pawar, G. V., van de Water, B., Cronin, M., & van Westen, G. J. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11535-1 · Cited by 10
The efficacy and safety of complementary and alternative medicine for depression: an umbrella review
Liu, Y., Yang, R., Zhang, N., & Liu, Q. (2024) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2024-3705 · Cited by 10
Tafazoli, A., Mikros, J., Khaghani, F., Alimardani, M., Rafigh, M., Hemmati, M., Siamoglou, S., Golińska, A. K., Kamiński, K. A., Niemira, M., et al. (2023) · Human Genomics · doi:10.1186/s40246-023-00508-1 · Cited by 10
Computational drug repurposing for viral infectious diseases: a case study on monkeypox
Saha, S., Chatterjee, P., Nasipuri, M., Basu, S., & Chakraborti, T. (2024) · Briefings in Functional Genomics · doi:10.1093/bfgp/elad058 · Cited by 10
Gervas‐Arruga, J., Barba-Romero, M. Á., Fernández-Martín, J., Gómez-Cerezo, J. F., Segú-Vergés, C., Ronzoni, G., & Cebolla, J. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910329 · Cited by 10
Kusch, M. K.-P., Zien, A., Hachenberg, C., Haefeli, W. E., & Seidling, H. M. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.103970 · Cited by 10
Artificial neural network (ANN) in drug delivery
Piroozmand, F., Mohammadipanah, F., & Sajedi, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89925-3.00005-8 · Cited by 10
PerDREP: Personalized Drug Effectiveness Prediction from Longitudinal Observational Data
Dey, S., Zhang, P., Sow, D., & Ng, K. (2019) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3292500.3330928 · Cited by 10
AntiviralDB: an expert-curated database of antiviral agents against human infectious diseases
Huang, J., Song, Q., Zhang, P., Deng, L., Gao, F., Deng, Y., Król, E., Růžek, D., Khouri, R., Clercq, E. D., et al. (2025) · mBio · doi:10.1128/mbio.02013-25 · Cited by 10
Large-scale prediction of adverse drug reactions-related proteins with network embedding
Park, J., Lee, S.-Y., Kim, K., Jung, J., & Lee, D. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac843 · Cited by 10
A Comprehensive Survey of Studies on Predicting Anatomical Therapeutic Chemical Classes of Drugs
Das, P., & Mazumder, D. H. (2024) · ACM Computing Surveys · doi:10.1145/3699713 · Cited by 10
Centrality analysis in a drug network and its application to drug repositioning
Keng, Y. Y., Kwa, K. H., & Ratnavelu, K. (2020) · Applied Mathematics and Computation · doi:10.1016/j.amc.2020.125870 · Cited by 10
Xu, F., Yang, Z., Wang, L., Meng, D., & Long, J. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad423 · Cited by 10
Self-Supervised Graph Information Bottleneck for Multiview Molecular Embedding Learning
Li, C., Mao, K., Wang, S., Yuan, Y., & Wang, G. (2023) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2023.3297576 · Cited by 10
Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions
Ru, X., Li, Z., Wei, L., Liu, Y., & Zou, Q. (2025) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.70056 · Cited by 10
Predicting Polypharmacy Side Effects Based on an Enhanced Domain Knowledge Graph
Wang, R., Li, T., Yang, Z., & Yu, H. (2020) · Communications in computer and information science · doi:10.1007/978-3-030-61702-8_7 · Cited by 10
Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling
Wang, Y., Gunashekar, D. R., Adam, T. J., & Zhang, R. (2017) · Studies in health technology and informatics · doi:10.3233/978-1-61499-830-3-614 · Cited by 10
A Review of Drug Side Effect Identification Methods
Deng, S., Sun, Y., Zhao, T., Hu, Y., & Zang, T. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200612163819 · Cited by 10
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
Langer, I., & Latek, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.711906 · Cited by 10
Supervised Pretraining for Molecular Force Fields and Properties PredictionPreprint
Gao, X., Gao, W., Xiao, W., Wang, Z., Wang, C., & Xiang, L. (2022) · arXiv (Cornell University) · doi:10.48550/arxiv.2211.14429 · Cited by 10
Dissez, G., Ceddia, G., Pinoli, P., Ceri, S., & Masseroli, M. (2019) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/3307339.3342154 · Cited by 10
Baek, B., & Lee, H. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05915-2 · Cited by 10
Fernández-Llaneza, D., VOS, R., Lieverse, J. E., Gosselt, H. R., Kane‐Gill, S. L., van Gelder, T., Klopotowska, J. E., Abu–Hanna, A., Dorgelo, A., ten Teije, A., et al. (2024) · Drug Safety · doi:10.1007/s40264-024-01474-w · Cited by 10
Pham, M., & Lichtarge, O. (2019) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789811215636_0039 · Cited by 10
Decoupling Weighing and Selecting for Integrating Multiple Graph Pre-training Tasks
Fan, T., Wu, L., Huang, Y., Lin, H., Tan, C., Gao, Z., & Li, S. Z. (2024) · International Conference on Learning Representations · doi:10.48550/arxiv.2403.01400 · Cited by 10
Authenticity and credibility aware detection of adverse drug events from social media
Hoang, T., Liu, J., Pratt, N. L., Zheng, V. W., Chang, K. C., Roughead, E. E., & Li, J. (2018) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2018.09.002 · Cited by 10
Formalizing drug indications on the road to therapeutic intent
Nelson, S. J., Oprea, T. I., Ursu, O., Bologa, C. G., Zaveri, A., Holmes, J., Yang, J. J., Mathias, S. L., Mani, S., Tuttle, M. S., et al. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx064 · Cited by 9
UniTox: Leveraging LLMs to Curate a Unified Dataset of Drug-Induced Toxicity from FDA Labels
Silberg, J., Swanson, K., Simon, E., Zhang, A., Ghazizadeh, Z., Ogden, S., Hamadeh, H., & Zou, J. (2024) · doi:10.1101/2024.06.21.24309315 · Cited by 9
“Many of these, such as SIDER [12], ECHA’s C&L system [13], PubChem’s Hazardous Substances Data Bank [14], and the Comparative Toxicogenomics Database [15], cannot be used to search by toxicity status and do not include all toxicity keywords in their side effects or phenotype data.”
medicX-KG: a knowledge graph for pharmacists’ drug information needs
Farrugia, L., Azzopardi, L. M., Debattista, J., & Abela, C. (2025) · Journal of Biomedical Semantics · doi:10.1186/s13326-025-00332-7 · Cited by 9
The rise of generative AI frameworks in drug discovery
Kotkondawar, R. R., Sutar, S. R., Kiwelekar, A. W., Kadam, V. J., & Jadhav, S. M. (2025) · International Journal of Data Science and Analytics · doi:10.1007/s41060-025-00831-x · Cited by 9
Navigating Healthcare Insights: A Bird’s Eye View of Explainability with Knowledge Graphs
Garg, S., Parikh, S. B., & Garg, S. (2023) · IEEE International Conference on Artificial Intelligence and Knowledge Engineering (AIKE) · doi:10.1109/aike59827.2023.00016 · Cited by 9
Utilizing AI and Social Media Analytics to Discover Adverse Side Effects of GLP-1 Receptor AgonistsPreprint
Bartal, A., Jagodnik, K. M., Pliskin, N., & Seidmann, A. A. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4790676 · Cited by 9
An Optimized Drug Similarity Framework for Side-effect Prediction
Zheng, Y., Ghosh, S., & Li, J. (2017) · Computing in cardiology · doi:10.22489/cinc.2017.128-068 · Cited by 9
Torres, L. H. M., Arrais, J. P., & Ribeiro, B. (2025) · Pattern Recognition · doi:10.1016/j.patcog.2025.111657 · Cited by 9
Chemical Property Relation Guided Few-Shot Molecular Property Prediction
Yao, S., Feng, Z., Song, J., Jia, L., Zhong, Z., & Song, M. (2022) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn55064.2022.9892419 · Cited by 9
Wang, H., Zhuang, L., Ding, Y., Tiwari, P., & Cheng, L. (2024) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2024.103029 · Cited by 9
Xuan, P., Cheng, T., Cui, H., Gu, J., Jin, Q., & Zhang, T. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00136 · Cited by 9
Literature-Based Enrichment Insights into Redox Control of Vascular Biology
Essack, M., Salhi, A., Stanimirović, J., Tifratene, F., Raies, A. B., Hungler, A., Uludağ, M., Neste, C. V., Trpković, A., Bajić, V., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1769437 · Cited by 9
Putative functional genes in idiopathic dilated cardiomyopathy
Nair, N. U., Das, A., Amit, U., Robinson, W., Park, S. G., Basu, M., Lugo, A., Leor, J., Ruppin, E., & Hannenhalli, S. S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18524-2 · Cited by 9
Kaveh, S., Mani‐Varnosfaderani, A., & Neiband, M. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-66173-z · Cited by 9
Hwang, Y., Oh, M., Jang, G., Lee, T., Park, C., Ahn, J., & Yoon, Y. (2017) · Molecular BioSystems · doi:10.1039/c7mb00059f · Cited by 9
Correia, R. B., Rozum, J. C., Cross, L. E., Felag, J., Gallant, M., Guo, Z., Herr, B. W., Min, A., Sánchez-Valle, J., Rocha, D. S., et al. (2025) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaf012 · Cited by 9
Azad, A., Fatima, S., Capraro, A., Waters, S. A., & Vafaee, F. (2021) · Patterns · doi:10.1016/j.patter.2021.100325 · Cited by 9
Causality Assessment of Adverse Drug Reaction: Controlling Confounding Induced by Polypharmacy
Dang, T.-T., Nguyen, T.-H., & Ho, T.-B. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190416115714 · Cited by 9
Toledano, J. P.-P., García‐Pedrajas, N., & García, G. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00611 · Cited by 9
Wu, S., Huang, L., Chen, J., Xie, X., Huang, S., & Xiao-jie, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1525307 · Cited by 9
Yi, J., Jiang, D., Wu, C., Zhang, X., He, W., Zhao, W., & Cao, D. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf408 · Cited by 9
Learning structured medical information from social media
Hasan, A., Levene, M., & Weston, D. J. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103568 · Cited by 9
Sieg at MEDIQA 2019: Multi-task Neural Ensemble for Biomedical Inference and Entailment
Bhaskar, S. A., Rungta, R., Route, J., Nyberg, E., & Mitamura, T. (2019) · BioNLP Workshop and Shared Task (BioNLP) · doi:10.18653/v1/w19-5049 · Cited by 9
On building a diabetes centric knowledge base via mining the web
Gong, F., Chen, Y., Wang, H., & Lu, H. (2019) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-019-0771-6 · Cited by 9
A hierarchical anatomical classification schema for prediction of phenotypic side effects
Wadhwa, S., Gupta, A., Dokania, S., Kanji, R., & Bagler, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193959 · Cited by 9
BioGraphFusion: graph knowledge embedding for biological completion and reasoning
Lin, Y., He, J., Chen, J., Zhu, X., Zheng, J., & Bo, T. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf408 · Cited by 9
Konkel, K., Öner, N., Ahmed, A., Jones, S. C., Berner, E. S., & Zengul, F. D. (2023) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad197 · Cited by 9
Pham, M., Wilson, S., Govindarajan, H., Lin, C.-H., & Lichtarge, O. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz857 · Cited by 9
Exploring Landscape of Drug-Target-Pathway-Side Effect Associations.
Lim, H., Poleksić, A., & Xie, L. (2018) · PubMed Central · Cited by 9
Uncovering Capabilities of Model Pruning in Graph Contrastive Learning
Wu, J., Chen, X., & Li, S. (2024) · ACM International Conference on Multimedia (ACM MM) · doi:10.1145/3664647.3681449 · Cited by 9
FusionMVSA: Multi-View Fusion Strategy With Self-Attention for Enhancing Drug Recommendation
Meng, Y., Zhang, Z., Shang, X., Tang, X., Li, J., Zhang, Z., Cui, F., Jin, S., Xu, J., & Wang, P. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3586758 · Cited by 9
Russom, M., Fitsum, Y., Abraham, A., & Savage, R. L. (2021) · Drugs - Real World Outcomes · doi:10.1007/s40801-021-00240-z · Cited by 9
In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax
Shilman, M. M., Bartolo, G., Alameh, S., Peterson, J. W., Lawrence, W. S., Peel, J. E., Sivasubramani, S. K., Beasley, D. W. C., Cote, C. K., Demons, S. T., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00190 · Cited by 9
Using Chemical-Induced Gene Expression in Cultured Human Cells to Predict Chemical Toxicity
Liu, R., Yu, X., & Wallqvist, A. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00287 · Cited by 8
Behrooznia, S., & Hooshmand, M. (2025) · ACS Omega · doi:10.1021/acsomega.5c04997 · Cited by 8
Koniuszewski, F., Vogel, F. D., Dajic, I., Seidel, T., Kunze, M., Willeit, M., & Ernst, M. C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1188101 · Cited by 8
Metadata
- Authors
- Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P.
- Affiliations
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University of Copenhagen (DK)
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-19
- Volume
- 44
- Issue
- D1
- Pages
- D1075-D1079
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702794
- OpenAlex
- W2145578524
- Cited by
- 1,451
- References
- 18
- Citations by year
- 2026: 123 · 2025: 199 · 2024: 194 · 2023: 160 · 2022: 156 · 2021: 183 · 2020: 131 · 2019: 111 · 2018: 82 · 2017: 74 · 2016: 37
- FWCI
- 51.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- European Molecular Biology Laboratory
- Novo Nordisk (NNF14CC0001)
- Novo Nordisk Fonden (NNF 14CC0001)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- SIDER, adverse drug reactions, drug safety, drug indications, package inserts, natural language processing, therapeutic target
- MeSH terms
- Drug Labeling, Internet, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.